Understanding Local Testing for Medical Devices & IVDs in Indonesia: Requirements & Registration Guide

The fastest way to derail a medical device registration in Indonesia is discovering halfway through your submission that you were supposed to run local laboratory tests first.

While local testing isn't a blanket requirement for every medical device, high-risk items and specific IVDs must undergo testing inside Indonesia before the Ministry of Health will approve your application.

This guide explains what medical device and IVD manufacturers need to know about navigating testing mandates and evaluating accredited laboratories. For support with your launch, explore Cisema’s services for medical device registration in Indonesia or contact us today.

What is Local Testing in Indonesia?

Local testing refers specifically to safety, quality, or performance evaluations performed inside Indonesia by a recognized or accredited laboratory. When required, the resulting report forms a non-negotiable part of your registration dossier.

Crucially, local testing is distinct from your routine R&D or internal quality control. It refers strictly to regulatory testing mandated by Indonesian authorities to prove compliance with local frameworks.

Health-sector licensing is governed by Ministry of Health Regulation (Permenkes) No. 11 of 2025, which sets overarching standards for risk-based business activities. To operationalize these standards, specific product guidelines (such as the Ministry's medical device registration manual) outline exactly which products require local lab verification.

Because these mandates directly gate dossier readiness, evaluating local testing obligations during initial strategy formulation, rather than after compiling your dossier, is essential to avoiding costly project delays.

When Is Local Testing Required for Medical Devices in Indonesia?

Determining whether your product needs local laboratory testing comes down to specific product characteristics and testing mandates rather than broad device classifications.

To check if your product is affected, start by reviewing the official circular letters (Surat Edaran) and regulatory updates published on the Ministry of Health's Regalkes portal. These official lists specify exactly which product types require local evaluation before registration.

For products that do trigger local testing, the Ministry evaluates specific safety and performance metrics against Indonesian National Standards (SNI) or recognized international benchmarks.

The table below illustrates common device categories and the specific parameters evaluated during local testing:

Note: This is an illustrative, non-exhaustive list.

Before sending any samples to Indonesia, make sure to confirm the exact testing method required for your product. A general laboratory approval is not enough — the testing facility you select must hold formal accreditation for the specific test protocol and standard needed to satisfy Ministry of Health evaluators.

Which IVDs Require Local Testing in Indonesia?

While medical devices are evaluated against general performance standards, local testing is particularly rigid for IVDs used to screen infectious markers in transfusion-transmitted diseases.

The requirement applies to:

• Rapid Hepatitis B surface antigen (HBsAg) tests
• Rapid HIV antibody tests
• Rapid Hepatitis C antibody tests
• Rapid syphilis tests
• Rapid malaria test kits used in malaria-endemic regions

For these specific assays, existing overseas clinical data does not automatically waive local testing requirements. Your regulatory planning must therefore clearly differentiate between data you already possess and data that must be generated locally.

What Testing Requirements Apply?

Once a product has been identified as subject to medical device or IVD testing in Indonesia, the next step is to establish exactly what must be demonstrated.

Before sending samples to a laboratory, manufacturers should confirm:

• The applicable standard or technical requirement
• The required test method
• The specific parameters to be tested
• Acceptance or minimum performance criteria
• Required sample quantities and specifications
• The documentation and format required for the final test report

Minimum Performance Requirements for Affected IVDs

For infectious disease screening assays, this means meeting strict, non-negotiable local sensitivity and specificity thresholds.

Comparing existing clinical data against these benchmarks before arranging local IVD testing in Indonesia allows you to identify potential gaps early, significantly reducing the risk of unexpected rejections or re-tests.

How to Select a Medical Device Testing Laboratory in Indonesia

Meeting technical requirements depends on choosing the right facility. Local testing must be performed by an Indonesian-accredited or Ministry of Health-designated laboratory listed in the official testing network on the e-Regalkes portal.

To ensure dossier acceptance, confirm that your chosen laboratory:

• Is authorized to test the relevant medical device or IVD category
• Can perform the required test method
• Uses the applicable standard or performance criteria
• Can provide documentation suitable for the registration dossier (learn more about preparing a registration dossier in our article)
• Has sufficient capacity to meet the planned registration timeline

Before submitting samples, manufacturers should also confirm the laboratory's requirements for sample quantity, product configuration, technical documentation, labelling, storage and transportation, and any other information needed to initiate testing.

To optimize your timeline, testing and dossier preparation can often run in parallel. Work closely with your Indonesian Authorized Representative (Indonesian License Holder) and regulatory team to establish which workstreams can proceed simultaneously and which must be finalized prior to submission.

Local Testing Timeline and Test Report Validity

Local testing typically requires 4 to 8 weeks, though actual schedules depend on several operational factors:

• Scope & Complexity: Device type, parameter depth, and sample availability
• Operational Capacity: Laboratory scheduling and current testing backlogs
• Documentation & Results: Completeness of technical files and whether repeat testing is required

Always confirm the expected turnaround time with your chosen facility before committing to a testing schedule.

Local test certificates issued by accredited laboratories in Indonesia are valid for up to two years from the date of issuance.

Always verify certificate issue dates during dossier assembly, especially if testing was completed well in advance. An otherwise compliant test report will trigger regulatory rejection if its validity expires during Ministry review.

De-Risking Your Timeline: How to Avoid the Local Testing Trap

Because local testing sits directly on your critical path to market access, any friction in the lab instantly translates to a delayed product launch.

Think of local testing not as a simple checklist item at the end of your project, but as a dynamic workstream that can either accelerate your entry or grind it to a halt.

Where Registrations Get Derailed

Even seasoned regulatory teams fall into predictable traps during Indonesian testing.

The most common speed bumps include:

• The Wrong Lab: Partnering with a facility that lacks specific accreditation for your exact device class or testing parameter.
• Mismatched Protocols: Conducting tests using similar international methods that local authorities ultimately reject in favor of specific Indonesian National Standards (SNI).
• Sample Logistics Stalls: Shipping insufficient sample quantities, lacking backup inventory, or dispatching kits without exact, compliant labeling.
• The "Expiration Clock" Trap: Completing testing too early, only for the two-year validity window to expire while the rest of your dossier is being assembled.
• Surprise Re-Tests: Unexpected failures triggered by miscommunicated testing parameters, forcing you back to square one.

A Proactive Local Testing Playbook

To safeguard your target launch date, treat local testing as an active, integrated strategy rather than a passive waiting period.

• Run Workstreams in Parallel: Don't wait for the final test report to start building your registration dossier. Prepare your administrative documents, device descriptions, and labeling frameworks while the lab evaluates your samples.
• Align Early with Your License Holder: Work closely with your Indonesian Authorized Representative to double-check that the chosen laboratory’s accreditation directly matches the Ministry of Health's exact expectations.
• Lock in Logistics Before Shipping: Confirm precise sample counts, storage conditions, customs declaration codes, and documentation prerequisites before anything leaves your facility.

By identifying potential testing dependencies from day one, you eliminate costly re-works, protect your budget, and ensure your submission dossier sails smoothly through Ministry review.

Final Thoughts: Taking Control of Your Testing Strategy

Local testing in Indonesia might feel like an added layer of regulatory complexity, but it doesn’t have to be a roadblock. While not every medical device or IVD requires local evaluation, knowing exactly where your product stands from day one makes all the difference between a smooth market entry and a stalled application.

By identifying your testing obligations early, choosing the right accredited laboratory, and running testing in parallel with your dossier preparation, you take full control of your registration timeline. This ultimately saves your team time, budget, and guesswork.

Translating these insights into flawless execution requires hands-on local expertise. With a local office in Indonesia, Cisema bridges the gap between Ministry of Health mandates and your commercial goals. Whether auditing your medical device and IVD portfolio for testing applicability, securing the right laboratory protocols, or streamlining your submission, our local regulatory team is ready to pave a clear, efficient path forward.

Contact Cisema today to discuss a tailored regulatory strategy for your medical device or IVD in Indonesia.

Further Information

Explore Cisema’s services for medical device registration in Indonesia.‍

Keep reading with our Indonesia regulatory guides:

• A Practical Guide to Medical Device Registration in Indonesia
• Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration
• A Guide to Dossier Preparation for Indonesia Medical Device Registration
• Key Requirements for Indonesia Halal Medical Devices: What Manufacturers & Importers Need to Know

References

• Minister of Health Regulation No. 11 of 2025 on Standards for Business Activities and Product/Service Standards for Risk-Based Business Licensing in the Health Subsector.
• Minister of Health Regulation No. 5 of 2026 on Medical Supplies. 
• Law No. 17 of 2023 on Health. 
• Government Regulation No. 28 of 2024 on the Implementing Regulation of Law No. 17 of 2023 on Health.
• Ministry of Health of the Republic of Indonesia: Medical Device Marketing Authorization Guide. 
• Medical Device Registration (e-Regalkes).
• Circular Letter: Update to the Network of Accredited Medical Device and Household Health Product Testing Laboratories (SNI ISO/IEC 17025:2017).